Finance

Lists
Why is CL up 2,15%?
Dive Deeper
CL:CNSX
Cresco Labs Inc
CAD 0,95
+2,15%
(+0,020) 1D
2 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CL...
Open
CAD 0,95
High
CAD 0,96
Low
CAD 0,88
Mkt. cap
336,49 m
Avg. vol.
81,33 k
Volume
144,74 k
52-wk high
CAD 3,12
52-wk low
CAD 0,88
EPS
-CAD 0,41
No. of employees
3 k
Open
CAD 0,95
High
CAD 0,96
Low
CAD 0,88
Mkt. cap
336,49 m
Avg. vol.
81,33 k
Volume
144,74 k
52-wk high
CAD 3,12
52-wk low
CAD 0,88
EPS
-CAD 0,41
No. of employees
3 k
News stories
From web sources and news partners
Profile
Cresco Labs, Inc. is a publicly traded, vertically integrated cannabis and medical marijuana company based in Chicago, Illinois, with current retail operations in nine states where marijuana has been legalized for medical use. The company's stock trades on the Canadian Securities Exchange under the ticker symbol CL, and in over-the-counter markets in the United States with the ticker symbol CRLBF. Wikipedia
About Cresco Labs Inc
CEO-
Employees2,9 k
Founded2013
HeadquartersChicago, Illinois, Verenigde State van Amerika
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
164,91 m
161,55 m
151,32 m
173,34 m
Cost of goods sold
85,55 m
78,23 m
75,88 m
86,39 m
Cost of revenue
85,55 m
78,23 m
75,88 m
86,39 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,53 m
60,43 m
59,36 m
66,63 m
Operating expense
59,17 m
65,40 m
64,28 m
73,59 m
Total operating expenses
144,72 m
143,63 m
140,15 m
159,98 m
Operating income
20,19 m
17,92 m
11,17 m
13,36 m
Other non operating income
4,21 m
4,23 m
1,34 m
-233,00 k
EBT including unusual items
-10,10 m
-87,15 m
-2,79 m
-3,60 m
EBT excluding unusual items
10,06 m
7,62 m
-2,75 m
-1,76 m
Income tax expense
11,87 m
1,80 m
14,22 m
-18,97 m
Effective tax rate
-117,48%
-2,07%
-508,95%
527,42%
Other operating expenses
-
-
-
-
Net income
-17,05 m
-87,59 m
-13,07 m
16,80 m
Net profit margin
-10,34%
-54,22%
-8,64%
9,69%
Earnings per share
0,01
-0,03
-0,04
0,06
Interest and investment income
699,00 k
1,30 m
407,00 k
407,00 k
Interest expense
-15,27 m
-15,63 m
-15,33 m
-15,51 m
Net interest expenses
-14,57 m
-14,33 m
-14,93 m
-15,10 m
Depreciation and amortization charges
5,64 m
4,97 m
4,92 m
6,96 m
EBITDA
33,05 m
28,68 m
23,39 m
26,02 m
Gain or loss from assets sale
-2,60 m
352,00 k
-
1,93 m
AI content may include mistakes. Learn more
Google-programme